HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jie Ma Selected Research

4,6-diamino-5-N-formamidopyrimidine (FAPy)

1/2022Urinary Metabolomic Study in a Healthy Children Population and Metabolic Biomarker Discovery of Attention-Deficit/Hyperactivity Disorder (ADHD).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jie Ma Research Topics

Disease

251Neoplasms (Cancer)
11/2022 - 01/2002
52Neoplasm Metastasis (Metastasis)
01/2022 - 02/2004
39Lung Neoplasms (Lung Cancer)
05/2022 - 06/2007
32Inflammation (Inflammations)
05/2022 - 07/2009
22Lymphatic Metastasis
12/2020 - 02/2004
21Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2022 - 10/2010
21Carcinoma (Carcinomatosis)
01/2021 - 02/2004
20Leukemia
02/2019 - 05/2002
19Infections
08/2022 - 07/2008
19Hepatocellular Carcinoma (Hepatoma)
05/2022 - 02/2010
19Carcinogenesis
01/2022 - 03/2012
18Breast Neoplasms (Breast Cancer)
01/2022 - 12/2003
16Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 08/2011
15Stomach Neoplasms (Stomach Cancer)
10/2021 - 02/2004
15Schizophrenia (Dementia Praecox)
01/2021 - 03/2003
14COVID-19
01/2022 - 01/2020
13Melanoma (Melanoma, Malignant)
01/2022 - 02/2010
12Hypoxia (Hypoxemia)
12/2021 - 03/2007
11Glioma (Gliomas)
02/2022 - 03/2012
11Disease Progression
11/2021 - 02/2010
10Body Weight (Weight, Body)
03/2022 - 08/2008
10Obesity
10/2021 - 01/2012
9Adenocarcinoma
01/2022 - 06/2007
9Squamous Cell Carcinoma of Head and Neck
01/2022 - 11/2012
9Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2012
9Pancreatic Neoplasms (Pancreatic Cancer)
12/2021 - 02/2005
9Ovarian Neoplasms (Ovarian Cancer)
11/2021 - 01/2002
9Alzheimer Disease (Alzheimer's Disease)
10/2021 - 07/2007
9Glioblastoma (Glioblastoma Multiforme)
10/2021 - 01/2016
9Sepsis (Septicemia)
11/2020 - 01/2011
9Lymphoma (Lymphomas)
10/2019 - 01/2003
8Osteosarcoma (Osteogenic Sarcoma)
11/2022 - 03/2009
8Aplastic Anemia (Anemia, Hypoplastic)
11/2022 - 04/2014
8Multiple Myeloma
06/2021 - 01/2007
8Adenocarcinoma of Lung
02/2021 - 01/2014
7Arthritis (Polyarthritis)
06/2022 - 06/2008
7Wounds and Injuries (Trauma)
02/2022 - 12/2011
7Traumatic Brain Injuries (Traumatic Brain Injury)
01/2022 - 06/2013
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 06/2007
7Hemorrhage
01/2022 - 04/2009
7Medulloblastoma
01/2021 - 01/2015
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2020 - 12/2005
6Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
05/2022 - 04/2016
6Experimental Arthritis
01/2020 - 06/2008
6Sleep Initiation and Maintenance Disorders (Insomnia)
01/2020 - 01/2014
5Autoimmune Diseases (Autoimmune Disease)
05/2022 - 06/2015

Drug/Important Bio-Agent (IBA)

107Proteins (Proteins, Gene)FDA Link
07/2022 - 03/2003
66Biomarkers (Surrogate Marker)IBA
06/2022 - 06/2007
44Messenger RNA (mRNA)IBA
02/2022 - 05/2002
40MicroRNAs (MicroRNA)IBA
10/2021 - 03/2012
30Pharmaceutical PreparationsIBA
01/2022 - 02/2004
24Biological ProductsIBA
10/2021 - 03/2007
22Long Noncoding RNAIBA
12/2021 - 12/2015
19CytokinesIBA
01/2022 - 04/2003
16DNA (Deoxyribonucleic Acid)IBA
05/2022 - 06/2007
15ErbB Receptors (EGF Receptor)IBA
05/2022 - 10/2010
14RNA (Ribonucleic Acid)IBA
12/2021 - 10/2013
14Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2018 - 05/2005
13Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2012
11Tyrosine Kinase InhibitorsIBA
05/2022 - 01/2009
11Adenosine Triphosphate (ATP)IBA
01/2020 - 03/2009
10Peptides (Polypeptides)IBA
12/2021 - 07/2007
10Phosphotransferases (Kinase)IBA
01/2020 - 03/2011
9AntigensIBA
05/2022 - 01/2002
9AntibodiesIBA
02/2021 - 01/2002
9Transcription Factors (Transcription Factor)IBA
01/2021 - 04/2011
9Small Interfering RNA (siRNA)IBA
01/2018 - 02/2011
9Neuroprotective AgentsIBA
01/2018 - 04/2009
8ParaffinIBA
11/2022 - 06/2007
8Cisplatin (Platino)FDA LinkGeneric
06/2022 - 08/2010
8Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 02/2004
8VaccinesIBA
01/2022 - 12/2013
8LigandsIBA
01/2022 - 01/2012
8Cadherins (E-Cadherin)IBA
01/2020 - 04/2011
7Amino AcidsFDA Link
06/2022 - 12/2008
7Therapeutic UsesIBA
06/2022 - 11/2012
7ProteomeIBA
01/2022 - 12/2008
7Sirolimus (Rapamycin)FDA Link
11/2021 - 09/2018
7Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 04/2012
7EnzymesIBA
12/2020 - 04/2010
7Liposomes (Liposome)IBA
05/2013 - 01/2003
6Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
07/2022 - 02/2005
6LipidsIBA
06/2022 - 12/2008
6Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 09/2010
6AutoantibodiesIBA
01/2022 - 11/2014
6Immunoglobulins (Immunoglobulin)IBA
01/2022 - 01/2002
6Indicators and Reagents (Reagents)IBA
12/2021 - 08/2015
6Caspase 3 (Caspase-3)IBA
11/2018 - 11/2012
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 04/2003
6Monoclonal AntibodiesIBA
01/2016 - 01/2002
5AntioxidantsIBA
06/2022 - 04/2010

Therapy/Procedure

86Therapeutics
08/2022 - 01/2002
26Drug Therapy (Chemotherapy)
06/2022 - 12/2008
18Immunotherapy
05/2022 - 04/2003
11Chinese Traditional Medicine (Traditional Chinese Medicine)
05/2022 - 01/2014
9Radiotherapy
01/2022 - 02/2005
9Transplantation
01/2021 - 07/2007
7Induction Chemotherapy
01/2022 - 11/2012
6Lasers (Laser)
01/2022 - 06/2007
6Aftercare (After-Treatment)
12/2020 - 04/2009